BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37936091)

  • 1. Predictors and outcomes of recurrent retroperitoneal liposarcoma: new insights into its recurrence patterns.
    Deng H; Gao J; Xu X; Liu G; Song L; Pan Y; Wei B
    BMC Cancer; 2023 Nov; 23(1):1076. PubMed ID: 37936091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors and outcomes of recurrent retroperitoneal liposarcoma with multiple tumors.
    Deng H; Xu X; Gao J; Huang J; Liu G; Song L; Wei B
    Front Med (Lausanne); 2023; 10():1161494. PubMed ID: 37746091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule.
    Park JO; Qin LX; Prete FP; Antonescu C; Brennan MF; Singer S
    Ann Surg; 2009 Dec; 250(6):977-82. PubMed ID: 19953716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.
    Singer S; Antonescu CR; Riedel E; Brennan MF
    Ann Surg; 2003 Sep; 238(3):358-70; discussion 370-1. PubMed ID: 14501502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome after surgical resection of multiple recurrent retroperitoneal soft tissue sarcoma.
    Willis F; Musa J; Schimmack S; Hinz U; Mechtersheimer G; Uhl M; Schmidt T; Fröhling S; Büchler MW; Schneider M
    Eur J Surg Oncol; 2021 Aug; 47(8):2189-2200. PubMed ID: 33980415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.
    MacNeill AJ; Miceli R; Strauss DC; Bonvalot S; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Raut CP; Gronchi A; Swallow CJ
    Cancer; 2017 Jun; 123(11):1971-1978. PubMed ID: 28152173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent retroperitoneal sarcomas: Clinical outcomes of surgical treatment and prognostic factors.
    Tropea S; Mocellin S; Damiani GB; Stramare R; Aliberti C; Del Fiore P; Rossi CR; Rastrelli M
    Eur J Surg Oncol; 2021 May; 47(5):1201-1206. PubMed ID: 32950313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of primary and repeated recurrent retroperitoneal liposarcoma: outcomes after aggressive surgeries at a single institution.
    Ishii K; Yokoyama Y; Nishida Y; Koike H; Yamada S; Kodera Y; Sassa N; Gotoh M; Nagino M
    Jpn J Clin Oncol; 2020 Dec; 50(12):1412-1418. PubMed ID: 32699905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution.
    Mussi C; Collini P; Miceli R; Barisella M; Mariani L; Fiore M; Casali PG; Gronchi A
    Cancer; 2008 Oct; 113(7):1657-65. PubMed ID: 18704991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of prognostic factors for liposarcoma].
    Zhang Q; Li JM; Liu JL; Wei YZ
    Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):943-948. PubMed ID: 31874553
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.
    Keung EZ; Hornick JL; Bertagnolli MM; Baldini EH; Raut CP
    J Am Coll Surg; 2014 Feb; 218(2):206-17. PubMed ID: 24315890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of intraoperative radiation therapy and high cumulative radiation doses in retroperitoneal soft tissue sarcoma.
    Willis F; Schimmack S; Uhl M; Haefner MF; Mechtersheimer G; Hinz U; Schmidt T; Debus J; Fröhling S; Schneider M
    Eur J Surg Oncol; 2020 May; 46(5):905-913. PubMed ID: 31892479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma.
    Tan MC; Brennan MF; Kuk D; Agaram NP; Antonescu CR; Qin LX; Moraco N; Crago AM; Singer S
    Ann Surg; 2016 Mar; 263(3):593-600. PubMed ID: 25915910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection?
    Tseng WW; Madewell JE; Wei W; Somaiah N; Lazar AJ; Ghadimi MP; Hoffman A; Pisters PW; Lev DC; Pollock RE
    Ann Surg Oncol; 2014 Jul; 21(7):2136-43. PubMed ID: 24705628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hibernation of masses suspected to be remnant tumors after surgical resection of retroperitoneal liposarcoma is related to improved overall survival.
    Rhu J; Lee KW; Park JB; Kim SJ
    Int J Clin Oncol; 2018 Aug; 23(4):765-774. PubMed ID: 29352382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage Surgery for Recurrent Retroperitoneal Well-Differentiated Liposarcoma: Early Reoperation may not Provide Benefit.
    Ikoma N; Roland CL; Torres KE; Chiang YJ; Wang WL; Somaiah N; Mann GN; Hunt KK; Cormier JN; Feig BW
    Ann Surg Oncol; 2018 Aug; 25(8):2193-2200. PubMed ID: 29520652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivisceral resection for retroperitoneal liposarcoma-is it worth it? A 20-year single-center experience.
    Teixeira FR; Arakaki MS; Lima HVG; Ferreira FO; Menegozzo CAM; Silva ER; Montero EFS; Oya T; Lima LC; Akaishi EH; Utiyama EM
    Surg Today; 2023 Oct; 53(10):1181-1187. PubMed ID: 37606758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative radiation therapy combined with radical surgical resection is associated with a lower rate of local recurrence when treating unifocal, primary retroperitoneal liposarcoma.
    Molina G; Hull MA; Chen YL; DeLaney TF; De Amorim Bernstein K; Choy E; Cote G; Harmon DC; Mullen JT; Haynes AB
    J Surg Oncol; 2016 Dec; 114(7):814-820. PubMed ID: 27634478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of high-grade retroperitoneal liposarcomas: personal experience.
    Milone M; Pezzullo LS; Salvatore G; Pezzullo MG; Leongito M; Esposito I; Milone F
    Updates Surg; 2011 Jun; 63(2):119-24. PubMed ID: 21455814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroperitoneal sarcoma: 25 years of experience with aggressive surgical treatment at the Institute of Oncology, Ljubljana.
    Erzen D; Sencar M; Novak J
    J Surg Oncol; 2005 Jul; 91(1):1-9. PubMed ID: 15999353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.